Health Care & Life Sciences » Pharmaceuticals | Wooridul Pharmaceutical Ltd.

Wooridul Pharmaceutical Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,860
4,645
2,133
4,502
6,079
Depreciation, Depletion & Amortization
1,041
914
821
759
1,130
Other Funds
1,605
1,312
624
1,573
784
Funds from Operations
1,214
2,419
3,578
6,834
7,994
Changes in Working Capital
2,991
402
44
921
6,156
Net Operating Cash Flow
4,205
2,017
3,622
7,755
1,838
Capital Expenditures
275
411
789
3,435
1,708
Sale of Fixed Assets & Businesses
8
5
1
2
2
Purchase/Sale of Investments
1,104
1,375
3,251
12,218
39
Net Investing Cash Flow
444
1,803
3,883
15,824
2,005
Issuance/Reduction of Debt, Net
565
4,590
1,276
9,929
83
Net Financing Cash Flow
565
5,563
1,276
9,929
83
Net Change in Cash
5,213
1,744
1,014
1,860
250
Free Cash Flow
4,456
2,420
2,850
4,639
300
Other Sources
972
78
522
36
71
Change in Capital Stock
-
-
974
-
-
Other Uses
45
100
366
209
330

About Wooridul Pharmaceutical

View Profile
Address
50 Pharmaceutical Ind. Complex 2-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.wooridulpharm.com
Updated 07/08/2019
Wooridul Pharmaceutical Ltd. engages in the development and production of medicaments. It operates through the following business divisions: ETC Drug, OTC Drug, Obesity Drug and Health Food. The company was founded on August 22, 1966 and is headquartered in Hwaseong, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.